See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.33▲ 1.43%
← RKH page
XStocksXray
Market X-Ray report · 27 October 2026

Rockhopper Exploration (RKH)

London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026

Key indicators

Last closeGBX 61.70
52-week range46.80 – 93.32
Return, 1 month / 3 months−6.5% / −14.7%
Return, 1 year / 3 years−20.7% / +382.0%
TrendBelow its 200-day average
RSI (14)54
Volatility (1 year)51.3%
Worst drawdown (1 year)-46.4%
Average daily value traded212.44M GBX
Dividend yield–

Market X-Ray price-based

34/ 100 · High confidence · ahead of 23% of stocks on this exchange
Trend22
Momentum19
Stability (higher is calmer)25
Liquidity92
Income–

Five-year price chart navy: price · brown: 200-day average

-0.3823.3947.1670.9294.692021-102023-012024-042025-072026-10

About the company

Rockhopper Exploration is an oil and gas exploration company whose work centres on the waters around the Falkland Islands. The company holds interests in offshore licences and has focused on appraising and developing the Sea Lion oil discovery, working with partners on plans for production. Its activities cover exploration, appraisal and development of hydrocarbon resources, and it is based in the United Kingdom.

On this site Rockhopper Exploration appears as a stock on the London Stock Exchange (UK), code RKH, with prices in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Rockhopper Exploration (RKH) trades on the London Stock Exchange in UK. It last closed at GBX 61.70 on 27 October 2026.

Its price-based Market X-Ray is 34 out of 100 (a weak price profile), ranking 2,918 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 20.7% and over the last three months it fell 14.7%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Rockhopper Exploration (RKH)

The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange

Lens and metricValueScoreReading
Trend22 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-14.8%
From 52-week high-31.1%
Momentum19 · WeakLagging most stocks on this exchange.
3-month return-14.7%
6-month return-25.7%
12-month return, skipping the last month-15.2%
Stability (higher is calmer)25 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)51.3%
Worst drawdown, 1 year (smaller is calmer)-46.4%
Liquidity92 · StrongTrades actively.
Average daily value traded212.44M GBX
Zero-volume days1.7%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+9.2%
1 month−6.5%
3 months−14.7%
6 months−25.7%
1 year−20.7%
3 years+382.0%
5 years+914.6%

Signals

50-day / 200-day average64.89 / 72.42
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)4.05

Technical summary

DailyBearish5 bullish · 1 neutral · 10 bearish
WeeklyStrongly bearish2 bullish · 1 neutral · 9 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026